Pharmaceutical Quality Submissions to Food & Drug Administration (PQ/CMC), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.20 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc/ and changes regularly. See the Directory of published versions
Contents:
This page provides a list of the FHIR artifacts defined as part of this implementation guide.
These are profiles on resources or data types that describe patterns used by other profiles, but cannot be instantiated directly. I.e. instances can conform to profiles based on these abstract profiles, but do not declare conformance to the abstract profiles themselves.
Manufacturing and/or Test Site Organization |
A profile for the data elements required to identify an organization that manufactures, processes or tests drug products or substances. |
Sponsor Organization |
A profile for the data elements required to identify the sponsor of the drug products or substances. |
Supplier Organization |
A profile for the data elements required to identify an organization that supplies drug products or substances. |
These define constraints on FHIR resources for systems conforming to this implementation guide.
CMC eCTD 32P10 Document |
Definition for a document bundle with the CMC eCTD 32P10 profiles. |
CMC eCTD 32S10 Document |
Definition for a document bundle with the CMC eCTD 32S1 profiles. |
CMC eCTD 32S23 Document |
Definition for a document bundle with the CMC eCTD 32S23 profiles. |
CMC eCTD SP4151 Document |
Definition for a document bundle with the CMC eCTD SP4151 profiles. |
Component Substance |
Any raw material intended for use in the manufacture of a drug substance, or any ingredient intended for use in the manufacture of a drug product including those that may not appear in such drug product. |
Document Reference Attachment |
A profile that represents the document or diagram in base64. |
Drug Product Component |
The amount details about the drug product components to define the product composition in a product unit. Use composition. |
Drug Product Container Closure |
Description and coding of the container closure system. Profile of Drug Product profile. |
Drug Product Description |
Includes the properties of the drug product and components. Profile of Drug Product profile. |
Excipient Drug Substance |
Provides sufficient information to identify an inactive substance and raw materials and its source when stability data is required in the submission. |
Manufactured Drug Product |
The manufactured drug product defined by all its parts or layers. If the drug product composition is homogeneous it will have a single part or component. |
Polymorphic Form |
Alternate structure present in the drug substance |
Quality Specification |
A quality specification is for a drug product or drug substance (excipient, API or raw material). |
Routine Drug Product |
Includes the identifying information of the drug product. Profile of Drug Product profile. |
Routine Drug Substance |
Provides sufficient information to identify a drug substance. Profile on Drug Substance profile. |
Substance General Information |
Substance General Information containting Drug Substance (Active Ingredient) nomenclature (2.3.S.1.1) and Substance Structure (2.3.S.1.2) profile. |
eCTD Product Description and Composition |
The fields needed to represent the Product Description, Container Closure and Composition of the Drug Product to be included under the 3.2.P.1.0 heading of the eCTD. References Sponsor Organization, Drug Product Description, and Product Container Closure System. |
eCTD Specification Composition |
The fields needed to Quality Specifications for APIs, Drug Substances, Excipients and Raw Materials. |
eCTD Substance Control of Materials Composition |
The fields needed to represent the Substance Control of Materials to be included under the eCTD 3.2.S.2.3 heading. References Sponsor Organization and Drug Substance Materials. |
eCTD Substance General Information |
The fields needed to represent the Substance Nomenclature and Structure to be included under the 3.2.S.1 heading of the eCTD. References Sponsor Organization. |
These define constraints on FHIR data types for systems conforming to this implementation guide.
PqAddress |
pq-specific Constraints on the Address datatype dealing with US addresses. |
These define constraints on FHIR data types for systems conforming to this implementation guide.
Additional Information |
Any additional information |
Container Closure |
The packaging information including a brief description of the components, the assembled packaging system and any precautions needed to ensure the protection and preservation of the drug substance or drug product during their use in the clinical trials. |
Content Percent |
constituent content percent |
Hierarchical Level |
Numeric level in the hierarchical value-set |
Interpretation Code |
A code that describes how to relate the given value to an acceptance value. |
Optional Denominator |
The constituent optional denominator is used then the unit is other than 1 per product part. |
Profile IG Version |
The IG version number of the bundle profile to which the instance conforms. Additionally, all the profiles of the resources in the bundle must conform to this version. |
Specification Type |
A classification of specification related to the kind of the entity it is referencing. |
Strength Extension |
Values required in Ingredient.substance.strength |
Test Order | Stage Sequence Order |
The sequential number assigned to each Test or Stage to specify the order of display on the Quality Specification. |
These define sets of codes used by systems conforming to this implementation guide.
Chemical Structure Data File Type Terminology |
Terminology used to qualify the information pertaining to chemical structure data file types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Closure Type Terminology |
Terminology used to qualify the information pertaining to closure types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Coating Purpose Terminology |
A category of terminology used to qualify the information pertaining to the coating purpose in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Code System PQCMC Product Characteristic |
Product Characteristic for the characteristic element in ManufacturedItemDefinition for product composition. |
Conformance to Criteria Terminology |
Terminology used to qualify the information pertaining to conformance to criteria in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Container Type Terminology |
Terminology used to qualify the information pertaining to container types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Drug Product Component Function Category Terminology |
Terminology used to qualify the information pertaining to drug product component function categories in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Drug Route Of Administration Terminology |
Terminology used for representation of the information on pharmaceutical product route of administration in the framework of the Structured Product Labeling documents. |
EVMPD Substance Classification |
EudraVigilance eXtended Medicinal Product Dictionary (XEVMPD) substance classes |
Excipient Function Terminology |
Terminology used to qualify the information pertaining to excipient functions in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
GENC Country Codes |
The GENC Standard specifies an information model for representing names and codes of geopolitical entities and administrative subdivisions, with supporting information. A geopolitical entity is a region controlled by a political community having an organized government and possessing internal and external sovereignty, most often as a State but sometimes having a dependent relationship on another political authority, or a special sovereignty status. Geopolitical entities may be divided into administratively subordinate divisions. A GENC code (or, synonymously, an ISO 3166 code element) for a geopolitical entity or administrative subdivision is a unique designation of that concept within a set of similar concepts established by a suitable authority. This information model is based on that of ISO 3166 but extended to capture additional information required by U.S. Government stakeholders. |
Interpretation Code Terminology |
Terminology used to qualify the information pertaining to numeric interpretation codes, Weight Operator codes and Amount Operator code in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Manufactured Dose Form Terminology |
Terminology used to qualify the information pertaining to the manufactured dose form. |
Name Part Terminology |
Terminology used to qualify the information pertaining to Name Part data in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
PQ/CMC Capsule Shell Classification Terminology |
A category of terminology used to qualify the information pertaining to the classification of a capsule in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Pharmaceutical Dosage Form Terminology |
Terminology used for representation of the information on pharmaceutical product dosage form in the framework of the SPL documents. |
Product Name Types Terminology |
Local value set of all codes in the Code system. |
Product Part Ingredient Physical Location Terminology |
A category of terminology used to qualify the information pertaining to the location of an ingredient within a product in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Product Part Type Terminology |
A category of terminology used to qualify the information pertaining to the product part type in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Quality Standard Terminology |
Terminology used to qualify the information pertaining to quality benchmarks in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Relationship Types Terminology |
Local value set of all codes in Relationship Types codes |
Release Mechanism Terminology |
A category of terminology used to qualify the information pertaining to release mechanism in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Release Profile Terminology |
A category of terminology used to qualify the information pertaining to release profile in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Source Type Terminology |
Terminology used to qualify the information pertaining to source types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Specification Status Terminology |
Terminology used to qualify the information pertaining to specification statuses in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Specification Type Terminology |
Terminology used to qualify the information pertaining to specification types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Strength Operator Terminology |
Terminology used to qualify the information pertaining to strength operators in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Strength Type Terminology |
Terminology used to qualify the information pertaining to strength types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Substance Name Type |
Waiting for NCIt codes are added for Product Ingredient Name Type |
Test Category Terminology |
Terminology used to qualify the information pertaining to test categories in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Test Method Origin Terminology |
Terminology used to qualify the information pertaining to test method origins in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Test Usage Terminology |
Terminology used to qualify the information pertaining to test usage in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Testing Site and Organization Identifier Type Terminology |
Terminology used to qualify the information pertaining to the sponsor or testing site unique identifier types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. |
Units Of Measure Terminology |
Terminology used to qualify the information pertaining to units of measure in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents. Note: Includes SPL Unit of Presentation Terminology |
eCTD sections Terminology |
Value set of all codes in Code system PQCMC Comp Section Types for bindings that require a value set instead of the code system. |
These define new code systems used by systems conforming to this implementation guide.
Code System PQCMC Comp Section Types |
Classification of a section of a PQ/CMC composition/document generally based on eCTD Module 3 section numbering for product and substance. A composition can have many section codes. |
Dummy EMA Codesystem |
This is a dummy codesystem representing EMA. It contains all the codes that are usable within the IG. It exists because the publisher previously allowed using value sets from codesystems that it could not find (e.g. https://www.ema.europa.eu). This is no longer the case, so a temp code system must be defined in the IG. |
Dummy NCIT Codesystem |
This is a dummy codesystem representing NCIt. It contains all the codes that are usable within the IG. It exists solely because NCIt currently cannot be validated against and because https://example.com/ codesystems are not allowed by the validator. |
GENC Country Codes |
The GENC Standard specifies an information model for representing names and codes of geopolitical entities and administrative subdivisions, with supporting information. A geopolitical entity is a region controlled by a political community having an organized government and possessing internal and external sovereignty, most often as a State but sometimes having a dependent relationship on another political authority, or a special sovereignty status. Geopolitical entities may be divided into administratively subordinate divisions. A GENC code (or, synonymously, an ISO 3166 code element) for a geopolitical entity or administrative subdivision is a unique designation of that concept within a set of similar concepts established by a suitable authority. This information model is based on that of ISO 3166 but extended to capture additional information required by U.S. Government stakeholders. |
Hierarchical Test Category Codes |
Waiting for NCIt codes to be added; then this may be deleted. |
Product Name Types Code Types |
IG only code system of all codes in Code system. |
Relationship Types Codes |
Local value set of all codes in the Relationship Types code system. |
These define transformations to convert between codes by systems conforming with this implementation guide.
ISO to GENC Country Code Mapping |
Maps between ISO 3166-1-3 and GENC. In 6.0.0, SubstanceDefinition.sourceMaterial.countryOfOrigin is bound to <https://build.fhir.org/valueset-country.html> which is all of ISO 3166 including both 2 and 3 letter codes but should only be GENC. |
These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like.
A DrugProductContainerClosure |
An example of section 3.2.P.1.2 for a multilayer product |
A DrugProductDescription for a multilayer product |
An example of section 3.2.P.1.1 |
A FinishedProduct profile based on ManufacturedItemDefinition |
An example of section 3.2.P.1.3 for a multilayer product |
A quality specification is for a drug product |
A quality specification is for a Drug Product |
A quality specification is for a drug substance |
A quality specification is for an API |
Base64 Document Reference - L-thyroxine-3D-structure-CT1000583834.sdf |
An attached SDfile. The ASCII file content is attached in base64. |
Base64 Document Reference - Levothyroid.png |
Base 64 Document - png file |
Base64 Document Reference - Monosodium_D-thyroxine_hydrate.png |
Monosodium D-thyroxine hydrate.png |
Bundle for 3.2.S.1 |
Bundle containng nomenclature and molecular structure |
CMCeCTDDocument32P10 bundle |
A bundle for 3.2.P.1.0 |
Carrageenan specification Example |
Example raw material (Carrageenan) specification for CTD 3.2.S.2.3. Raw matrials and Excipients share the same profile but are in different bundles. |
Citric acid specification Example |
Example raw material (Citric acid) specification for CTD 3.2.S.2.3 |
Composition ingredient substance indentifying information - Maize starch |
An excipient in the two layer tablet |
Composition ingredient substance indentifying information - acetaminophen |
An API used in two layer table example. |
Composition ingredient substance indentifying information - aspirin |
API used in two layer table example |
Drug Manufacturing Site - Vandechemie |
Example of Manufacturing site using the MfgTestSiteOrganization profile - Vandechemie |
Drug Substance Nomenclature and Structure |
LEVOTHYROXINE SODIUM ANHYDROUS |
DrugProductComponent example for an excipient - Maize starch |
Strength is captured for all excipients |
East-West Manufacturing |
Manufacture of Chemicals |
EctdComposition32P10 for 2 layer tablet |
eCTD Product Description and Composition for the two layer tablet example |
Example Composition for CTD 3.2.S.2.3 |
This composition contains one section with reference to each raw material specification for the drug substance. |
Example RoutineSubstanceDefinition |
Provides sufficient information to identify a drug substance |
Example RoutineSubstanceDefinition for Asprin |
Identification of the Drug Substance of the raw materials whose specifications are |
Example SubstanceDefinition for Carrageenan |
Identification of the subject of the specification which is a sourced plant based raw materials. It contains the sourceMaterial backbone elements. |
Example SubstanceDefinition for anhydrous citric acid |
Identification of the subject of the specification. It is commonly used in the pharmaceutical industry as a stabilizer and preservative. |
Example SubstanceDefinition for water |
Identification of the subject of the specification |
Example of MfgTestSiteOrganization profile on Organization |
A profile for the data elements required to identify an organization that manufactures, processes or tests drug products or substances. |
Example of a Supplier Organization |
This example if for a Supplier Organization |
FHIR Document example of 3.2.P.4.1. |
FHIR document bundle with the CMC eCTD SP4151 profile for a Drug Substance |
FHIR Document example of 3.2.P.5.1. |
FHIR document bundle with the CMC eCTD SP4151 profile for a Drug Product |
IngredComponentSubstance example showing the use of the sourceMaterial backbone element |
ComponentSubstance example showing the use use of the sourceMaterial backbone element |
Manufacturing Site (J. Jones Research) |
Manufacturing site instance of an Organization Example. There will be a type code in future |
Polymorphic Form Example |
Polymorphic Form - DextroThyroxine |
Sponsor of API |
SponsorOrganization - Large Life |
SponsorOrganization - Wunderwerke |
A company sponsor of a drug application |
SponsorOrganization J. Jones Research |
Example of a Sponsor type of Organization |
Strength info for the Active Ingredient |
one of the active ingredients in the two layer table example - aspirin |
Strength information - Grape skin extract |
Example of a DrugProductComponent for an Inactive Ingredient |
Strength information for the Active Ingredient - acetaminophen |
An active ingredient in the two layer table example - acetaminophen |
Vidinaid |
Manufacturing site (Vidinaid) instance with second address line |
Water Specification Example |
Example raw material (water) specification for CTD 3.2.S.2.3 |
drug product for specification |
Includes the identifier of the drug product |
eCTD Composition for 3.2.S.1 |
Composistion containing eCTD Substance General Information |
eCTD Document for 32S23 |
This is an example of the Substance Control of Materials bundle profile. It is to submit Module 3 of CTD 3.2.S.2.3 folder content to the FDA. |
eCTD Drug Substance Specification Composition SP4151 |
Composition SP4151 implementing eCTD 3.2.S.4.1. |
eCTD Product Specification Composition SP4151 |
Composition SP4151 implementing eCTD 3.2.P.5.1. |